Welcome to LookChem.com Sign In|Join Free

CAS

  • or

398491-59-3

Post Buying Request

398491-59-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

398491-59-3 Usage

General Description

5N-BOC-3-AMINO-4,6-DIHYDRO-1H-PYRROLO[3,4-C]PYROZOLE is a chemical compound with the molecular formula C16H20N4O2. It is a pyrrolopyrazole derivative and is often used in the synthesis of pharmaceuticals and agrochemicals. 5N-BOC-3-AMINO-4,6-DIHYDRO-1H-PYRROLO[3,4-C]PYROZOLE is notable for its BOC (tert-butyloxycarbonyl) protected amine group, which makes it useful in organic synthesis for protecting other functional groups while reactions are carried out. The compound is also known for its potential interactions with biological targets, making it a subject of interest in medicinal and pharmaceutical research. Overall, 5N-BOC-3-AMINO-4,6-DIHYDRO-1H-PYRROLO[3,4-C]PYROZOLE is a versatile chemical with potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 398491-59-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,8,4,9 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 398491-59:
(8*3)+(7*9)+(6*8)+(5*4)+(4*9)+(3*1)+(2*5)+(1*9)=213
213 % 10 = 3
So 398491-59-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H18N4O2/c1-10(2,3)16-9(15)14-4-6-7(5-14)12-13-8(6)11/h6-7,12H,4-5H2,1-3H3,(H2,11,13)

398491-59-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl 3-amino-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate

1.2 Other means of identification

Product number -
Other names tert-butyl 3-amino-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazole-5-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:398491-59-3 SDS

398491-59-3Downstream Products

398491-59-3Relevant articles and documents

Dipeptidyl peptidase-IV inhibitor-aminotetrahydropyrane derivative

-

Paragraph 0103; 0104; 0105, (2017/07/23)

The invention provides a DPPIV inhibitor which has the structure shown as the formula (I) (please see the formula (I) in the description). Experiments show that the inhibitor can effectively inhibit the activity of dipeptidyl peptidase IV (DPPIV) and be used for preventing DPPIV-mediated diseases or delaying progress of the DPPIV-mediated diseases or treating the DPPIV-mediated diseases, particularly 2 type and 1 type diabetes, obesity, arthritis, osteoporosis and part of tumors. The invention further provides a preparation method of the inhibitor.

The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors

Cox, Jason M.,Chu, Hong D.,Kuethe, Jeffrey T.,Gao, Ying-Duo,Scapin, Giovanna,Eiermann, George,He, Huaibing,Li, Xiaohua,Lyons, Kathryn A.,Metzger, Joseph,Petrov, Aleksandr,Wu, Joseph K.,Xu, Shiyao,Sinha-Roy, Ranabir,Weber, Ann E.,Biftu, Tesfaye

, p. 2622 - 2626 (2016/05/09)

Novel potent and selective 5,6,5- and 5,5,6-tricyclic pyrrolidine dipeptidyl peptidase IV (DPP-4) inhibitors were identified. Structure-activity relationship (SAR) efforts focused on improving the intrinsic DPP-4 inhibition potency, increasing protease se

Structure-activity-relationship of amide and sulfonamide analogs of omarigliptin

Chen, Ping,Feng, Dennis,Qian, Xiaoxia,Apgar, James,Wilkening, Robert,Kuethe, Jeffrey T.,Gao, Ying-Duo,Scapin, Giovanna,Cox, Jason,Doss, George,Eiermann, George,He, Huaibing,Li, Xiaohua,Lyons, Kathryn A.,Metzger, Joseph,Petrov, Aleksandr,Wu, Joseph K.,Xu, Shiyao,Weber, Ann E.,Yan, Youwei,Roy, Ranabir Sinha,Biftu, Tesfaye

, p. 5767 - 5771 (2015/11/24)

A series of novel substituted-[(3R)-amino-2-(2,5-difluorophenyl)]tetrahydro-2H-pyran analogs have been prepared and evaluated as potent, selective and orally active DPP-4 inhibitors. These efforts lead to the discovery of a long acting DPP-4 inhibitor, omarigliptin (MK-3102), which recently completed phase III clinical development and has been approved in Japan.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 398491-59-3